EXAGEN INC.

XGN

Exchange: Nasdaq
Industry: Services-Medical Laboratories
SEC CIK: 0001274737

SEC filings (opens in a new tab)

Insider trades, last 90 days

0 buys · 1 sell

Sold $148.78K
Open-market purchases (P) and sales (S), counted by Form 4 filing.

View insider trades

13F holders, Q2 2026

57

−4 vs. Q1 2026
Total value $38.38M

View 13F holders

Superinvestors holding XGN

0

None of the superinvestors held XGN at the end of Q2 2026.

See all holders

Price chart

Chart by TradingView (opens in a new tab)

Latest insider trades

Open-market purchases and sales by XGN insiders, newest first.

Insider trades
Filed (ET)	Trade date	Insider	Transaction	Shares	Avg price	Value	Shares after	Holding change	Filing
Sep 2, 20265:39 PM ET	Sep 1, 2026	Black Jeffrey G.Chief Financial Officer	SSaleCommon Stock	−20.61K	$7.2175	−$148.78K	323.34K	−6.0%	SEC
Mar 4, 2026	Mar 3, 2026	ABALLI JOHNPresident and CEO	SSaleCommon Stock	−15.7K	$3.62	−$56.83K	687.3K	−2.2%	SEC
Feb 25, 2026	Feb 24, 2026	ABALLI JOHNPresident and CEO	SSaleCommon Stock	−11.43K	$3.61	−$41.26K	703K	−1.6%	SEC
Feb 25, 2026	Feb 24, 2026	Black Jeffrey G.Chief Financial Officer	SSaleCommon Stock	−1.58K	$3.61	−$5.72K	267.44K	−0.6%	SEC
Oct 20, 2025	Oct 16, 2025	ABALLI JOHNPresident and CEO	SSaleCommon Stock	−31.79K	$11.82	−$375.72K	714.43K	−4.3%	SEC

Top 5 13F holders, Q2 2026

The largest institutional positions in XGN at the end of Q2 2026.

Institutions holding XGN in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
WEXFORD CAPITAL LP	792,855	$3.69M	0.51%	00.0%	Unchanged
NANO CAP NEW MILLENNIUM GROWTH FUND L P	675,000	$3.14M	2.41%	+90,000+15.4%	Added
First Eagle Investment Management, LLC	613,930	$2.85M	0.00%	+488,688+390.2%	Added
VANGUARD CAPITAL MANAGEMENT LLC	612,832	$2.85M	0.00%	−65,820−9.7%	Reduced
FourWorld Capital Management LLC	596,528	$2.77M	3.21%	+156,578+35.6%	Added